2023
Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring
Galderisi A, Kariyawasam D, Stoupa A, Quoc A, Pinto G, Viaud M, Brabant S, Beltrand J, Polak M, Samara-Boustani D. Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring. European Journal Of Endocrinology 2023, 189: k19-k24. PMID: 37952170, DOI: 10.1093/ejendo/lvad147.Peer-Reviewed Original ResearchConceptsClassical congenital adrenal hyperplasiaClassical CAHCongenital adrenal hyperplasiaContinuous glucose monitoringLower cortisol concentrationsGlucose patternsAdrenal hyperplasiaCortisol concentrationsGlucose monitoringFludrocortisone replacement therapySensor glucose valuesHydrocortisone doseAcute illnessAsymptomatic hypoglycemiaWhole cohortNighttime hypoglycemiaReplacement therapyPercentage of timeObservational studyGlucose profilesGlycemic patternsSerial measuresGlucose valuesDaily cortisolHypoglycemia
2019
Mapping hemodynamic changes during hypoglycemia in the very preterm neonatal brain: preliminary results
Brigadoi S, Galderisi A, Pieropan E, Cooper R, Cutini S, Baraldi E, Cobelli C, Dell'Acqua R, Sparacino G, Trevisanuto D. Mapping hemodynamic changes during hypoglycemia in the very preterm neonatal brain: preliminary results. Progress In Biomedical Optics And Imaging 2019, 11074: 110740e-110740e-3. DOI: 10.1117/12.2526974.Peer-Reviewed Original ResearchVery preterm neonatesSevere hypoglycemic eventsHypoglycemic eventsContinuous glucose monitoringPreterm neonatesHemodynamic changesMild hypoglycemic eventsPoor neurological outcomePreterm neonatal brainTight glycemic controlFuture clinical trialsNeurological outcomeGlycemic controlPreterm populationVery pretermGlycemic variabilityClinical trialsNeonatal brainNewborn brainClinical problemHypoglycemiaHyperglycemic eventsFirst weekBrain hemodynamicsGlucose monitoring
2016
Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe
Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Calore R, Moncada Y, Galasso S, Galderisi A, Vallone V, Di Palma F, Losiouk E, Lanzola G, Tinti D, Rigamonti A, Marigliano M, Zanfardino A, Rapini N, Avogaro A, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D. Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe. Diabetes Care 2016, 39: 1180-1185. PMID: 27208335, DOI: 10.2337/dc15-2815.Peer-Reviewed Original ResearchConceptsSensor-augmented pumpCrossover trialMean glucoseArtificial pancreasType 1 diabetesArtificial Pancreas ProjectWearable artificial pancreasAP trialOlder childrenTrialsHypoglycemiaYoung childrenChildrenPancreasOvernight timeSignificant changesGlucoseDaysDiabetesOutpatientsResearch designThreefold reduction